Trials / Completed
CompletedNCT04530175
Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC)
Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to validate a mathematical modeling of treatment by intermittent hemodialysis using regional citrate anticoagulation with a dialysate containing calcium
Detailed description
The only visit to the study will be carried out during a usual dialysis session in the intensive care unit of Clermont-Ferrand University Hospital. In addition to the usual care, 2 blood samples will be taken from the blood circuit 1 hour after the start of the hemodialysis session by the nurse in charge of the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood sampling | 2 blood samples will be taken from the blood circuit 1 hour after the start of the hemodialysis session by the nurse in charge of the patient. |
Timeline
- Start date
- 2021-02-02
- Primary completion
- 2021-07-07
- Completion
- 2021-07-07
- First posted
- 2020-08-28
- Last updated
- 2022-02-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04530175. Inclusion in this directory is not an endorsement.